Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02997345 · ClinicalTrials.gov registry record
PPROM Registry (Preterm Premature Rupture of Membranes)
A clinical trial of Premature Birth and Oligohydramnios, sponsored by American Alliance for pProm Support.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT02997345: Recruiting study of Premature Birth and Oligohydramnios, sponsored by American Alliance for pProm Support.
NCT02997345 is a study of Premature Birth and Oligohydramnios that is actively recruiting participants, run by American Alliance for pProm Support. The registered enrollment target is 3,000 participants, above the 315-participant average among 38 other Premature Birth trials with a reported enrollment target (852% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02997345, a study of Premature Birth and Oligohydramnios, is actively recruiting participants, sponsored by American Alliance for pProm Support.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Preterm Premature Rupture of Membranes (PPROM) before 37 weeks of pregnancy is responsible for 40% of preterm births in the United States. The PPROM Registry aims to identify possible causes of PPROM, evaluate trends in expectant management, measure maternal and fetal care, and to review short term and long term outcomes of affected pregnancies and births.
Conditions Studied
Interventions
- OTHER There is no intervention associated with this study.
Study Locations (1)
Colorado
- Www.Aapprom.Org/the-Registry - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2013-07 |
| Est. Completion | 2030-12 |
What NCT02997345 shows while recruiting
NCT02997345 is an observational study that tracks outcomes without assigning an intervention. Its 3,000 participants enrollment target places it among the larger protocols in the corpus, above the 315-participant average among 38 other Premature Birth trials with a reported enrollment target (852% higher).
The record links to 4 conditions, with Premature Birth appearing as the primary indexed condition, and to 1 intervention - of which There is no intervention associated with this study. is the first listed.
NCT02997345 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02997345 about?
NCT02997345 is a clinical study titled "PPROM Registry (Preterm Premature Rupture of Membranes)". Preterm Premature Rupture of Membranes (PPROM) before 37 weeks of pregnancy is responsible for 40% of preterm births in the United States. The PPROM Registry aims to identify possible causes of PPROM, evaluate trends in expectant management, measure maternal and fetal care, and to review short term ...
What is the current status of trial NCT02997345?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2013-07. Estimated completion is 2030-12.
What conditions does trial NCT02997345 study?
This clinical trial studies the following conditions: Premature Birth, Oligohydramnios, Fetal Membranes, Premature Rupture, Preterm Premature Rupture of the Membranes.
What interventions are being tested in trial NCT02997345?
The interventions under investigation include: There is no intervention associated with this study. (OTHER).
Who is sponsoring clinical trial NCT02997345?
This trial is sponsored by American Alliance for pProm Support, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02997345 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02997345's enrollment target sits among peer trials
3,000 2nd of 38 the highest of 38 other Premature Birth trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Premature Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age
RECRUITING · Phase 4
-
A Randomized Controlled Trial of Impact of Wearable, Wireless Breast Pumps on Frequency and Efficacy of Milk Expression in Mothers of Premature Infants
RECRUITING · NA
-
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
RECRUITING · NA
-
The Periviable GOALS Decision Support Tool
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
- NCT00816114 · 3,000 participants
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia